Smaller gold mining companies expected to outperform market

ON SPECIALIST MARKETS

clock

The gold price has been the subject of much debate recently as public debt problems continue to mount and investors look for stores of value alternative to the leading currencies.

We believe even if gold remains at current levels, smaller gold mining companies’ shares should outperform the market, the gold price and the sector. In 2009, investors focused on more liquid mid-capitalisation mining companies with trading liquidity, enabling them to adjust their investment strategy swiftly. This year we have seen the focus shifting towards smaller capitalisation companies. Junior miners with substantial reserves in the ground, growth in cashflow, little or no debt and experienced management teams that continue to explore and add to their reserve base are most likely to...

To continue reading this article...

Join Investment Week for free

  • Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
  • Get ahead of regulatory and technological changes affecting fund management
  • Important and breaking news stories selected by the editors delivered straight to your inbox each day
  • Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
  • Be the first to hear about our extensive events schedule and awards programmes

Join now

 

Already an Investment Week
member?

Login

More on Specialist

Deep Dive: Thematics offer diversification but investors must consider bond sensitivity

Deep Dive: Thematics offer diversification but investors must consider bond sensitivity

‘Dedicated specialists’

James Baxter-Derrington
clock 06 April 2023 • 4 min read
European private equity yet to spend €270bn worth of capital

European private equity yet to spend €270bn worth of capital

Deployment of capital expected

Kathleen Gallagher
clock 04 January 2023 • 1 min read
Early-stage biopharma: An opportunity for strategic investment

Early-stage biopharma: An opportunity for strategic investment

Disproportionately smaller investment

Ali H. Munawar
clock 10 August 2022 • 4 min read
Trustpilot